Kroger Health, the healthcare arm of the grocery store chain, has teamed up with genetic testing company Myriad Genetics, on a pilot meant to help employees receive personalized treatments for depression.
The Cincinnati, Ohio-based company is offering select Kroger Health Plan members access to Myriad’s GeneSight, which analyzes specific genes as a way to predict the effectiveness of 56 common medications for depression. This information can be used by clinicians to more effectively target treatments to help ease patient symptoms.
Click here to read the complete article.
Story excerpt provided by MedCity News.
Written by Kevin Truong.
Originally published July 14, 2019.